Published in Invest Ophthalmol Vis Sci on October 01, 2001
Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland. Invest Ophthalmol Vis Sci (2011) 0.95
Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model. Graefes Arch Clin Exp Ophthalmol (2008) 0.87
Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci (2007) 0.84
Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background. Exp Eye Res (2014) 0.75
Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 4.08
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest (1972) 2.61
Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum (2010) 2.52
Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol (1998) 2.50
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (1998) 2.14
Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77
Subgroups of gamma-A immune globulins. Proc Soc Exp Biol Med (1966) 1.73
A comparative histologic study of the fibrillin microfibrillar system in the lens capsule of normal subjects and subjects with Marfan syndrome. Invest Ophthalmol Vis Sci (1998) 1.71
Recombination of heavy and light chains of human gamma-a-myeloma proteins: formation of hybrid molecules and configurational specificity. J Exp Med (1966) 1.45
Immunohistochemical localization of fibrillin in human ocular tissues. Relevance to the Marfan syndrome. Arch Ophthalmol (1995) 1.44
An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci (1981) 1.44
Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother (2000) 1.35
Characterization of the serum and secretory immune systems of the cow and sheep. J Immunol (1969) 1.33
Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog (1997) 1.30
Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol (2001) 1.30
Experimental viral-induced congenital encephalopathies. I. Pathology of hydranencephaly and porencephaly caused by bluetongue vaccine virus. Lab Invest (1971) 1.28
Chlamydia and associated arthritis. Curr Opin Rheumatol (2000) 1.25
Oral immunization with chlamydial major outer membrane protein (MOMP). Invest Ophthalmol Vis Sci (1988) 1.25
Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum (1992) 1.22
Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum (2001) 1.22
Experimental viral-induced congenital encephalopathies. II. The pathogenesis of bluetongue vaccine virus infection in fetal lambs. Lab Invest (1971) 1.21
Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes. Med Microbiol Immunol (1998) 1.20
Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun (2001) 1.18
Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest Ophthalmol Vis Sci (1986) 1.15
Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis Rheum (1996) 1.12
Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects. Arthritis Rheum (1999) 1.08
Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4. J Exp Med (1987) 1.08
Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol (1992) 1.08
T cells and trachoma. Their role in cicatricial disease. Ophthalmology (1991) 1.05
Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med (1995) 1.05
Genes required for assembly and function of the protein synthetic system in Chlamydia trachomatis are expressed early in elementary to reticulate body transformation. Mol Gen Genet (1997) 1.05
Oral immunization against chlamydial eye infection. Invest Ophthalmol Vis Sci (1987) 1.02
Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog (2000) 1.02
Intracellular location of inapparently infecting Chlamydia in synovial tissue from patients with Reiter's syndrome. Immunol Res (1994) 1.02
RNA-directed molecular hybridization screening: evidence for inapparent chlamydial infection. Am J Med Sci (1991) 1.02
Case report: in situ hybridization for detection of inapparent infection with Chlamydia trachomatis in synovial tissue of a patient with Reiter's syndrome. Am J Med Sci (1995) 0.99
Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma. Curr Eye Res (1992) 0.98
Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs. Ann Trop Med Parasitol (2004) 0.96
Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum (2000) 0.96
An analysis of fish genomes by density gradient centrifugation. Eur J Biochem (1980) 0.96
A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats. J Immunol (2001) 0.95
Microfibril abnormalities of the lens capsule in patients with Marfan syndrome and ectopia lentis. Ophthalmic Genet (2000) 0.95
Reactive arthritis: preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg (2000) 0.94
Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum (1999) 0.94
Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res (2003) 0.93
Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8. Am J Ophthalmol (2001) 0.93
Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection. Nat Med (1996) 0.93
Identification of Chlamydia trachomatis in the human temporomandibular joint. J Oral Maxillofac Surg (1999) 0.92
B-lymphocyte mediated cytolysis: a complement independent phenomenon. Immunol Commun (1972) 0.92
Interleukin-1 is a mucus secretagogue. Cell Immunol (1991) 0.92
A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. Invest Ophthalmol Vis Sci (1995) 0.91
Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum. Ann Rheum Dis (2008) 0.91
Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells. Invest Ophthalmol Vis Sci (1985) 0.91
A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis. Invest Ophthalmol Vis Sci (1985) 0.91
Phospholipase A2-activating protein induces the synthesis of IL-1 and TNF in human monocytes. J Immunol (1995) 0.91
Chlamydia-specific lymphocytes in conjunctiva during ocular infection: limiting dilution analysis. Reg Immunol (1991) 0.90
Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers. Infect Immun (1999) 0.90
Changes in conjunctival lymphocyte populations induced by oral immunization with Chlamydia trachomatis. Curr Eye Res (1986) 0.90
Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci (2000) 0.89
Activated macrophages in experimental subretinal neovascularization. Ophthalmologica (1990) 0.89
Mitochondrial involvement in bladder function and dysfunction. Mol Cell Biochem (1999) 0.88
Angiogenic lymphokines of activated T-cell origin. Invest Ophthalmol Vis Sci (1983) 0.88
Primary rejection of skin allografts in the anterior chamber of the rabbit eye. J Immunol (1970) 0.88
Monosodium urate, hydroxyapatite, and calcium pyrophosphate crystals induce tumor necrosis factor-alpha expression in a mononuclear cell line. J Rheumatol (1997) 0.88
Murine models of Sjögren's syndrome. Adv Exp Med Biol (1994) 0.88
Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection. Infect Immun (1992) 0.87
Murine model of ocular infection by a human biovar of Chlamydia trachomatis. Invest Ophthalmol Vis Sci (1995) 0.87
Preparation of RNA from unspheroplasted yeast cells (Saccharomyces cerevisiae). Anal Biochem (1989) 0.87
Viability of Chlamydia trachomatis in fallopian tubes of patients with ectopic pregnancy. Fertil Steril (1998) 0.87
Attempted oral immunization with chlamydial lipopolysaccharide subunit vaccine. Invest Ophthalmol Vis Sci (1987) 0.87
Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells. Cancer Res (1991) 0.87
Optimised sample DNA preparation for detection of Chlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction. Ann Rheum Dis (2001) 0.86
Invertebrate protein simulating mediators of delayed hypersensitivity. Nature (1970) 0.86
Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions. Invest Ophthalmol Vis Sci (1991) 0.86
Aetiological agents: their molecular biology and phagocyte-host interaction. Baillieres Clin Rheumatol (1998) 0.86
The effect of sea star coelomocyte extract on cell-mediated resistance to Listeria monocytogenes in mice. J Exp Med (1974) 0.86
An immunogenetic analysis of resistance to herpes simplex virus retinitis in inbred strains of mice. Invest Ophthalmol Vis Sci (1987) 0.85
Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpesvirus retinopathy: association with inflammation and viral infection. Histol Histopathol (2001) 0.85
Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains. Invest Ophthalmol Vis Sci (1988) 0.85
Experimental autoimmune dacryoadenitis. I. Lacrimal gland disease in the rat. Invest Ophthalmol Vis Sci (1987) 0.85
Down-regulation of Ia expression on macrophages by sea star factor. Cell Immunol (1985) 0.84
Effect of bacterial secondary infection in an animal model of trachoma. Infect Immun (1984) 0.83
Patch clamp and atomic force microscopy demonstrate TATA-binding protein (TBP) interactions with the nuclear pore complex. J Membr Biol (1995) 0.83